Breaking News Instant updates and real-time market news.

MDSO

Medidata

$73.30

-0.83 (-1.12%)

, VEEV

Veeva

$105.26

1.36 (1.31%)

09:20
09/25/18
09/25
09:20
09/25/18
09:20

Medidata price target lowered to $91 from $98 at RBC Capital

RBC Capital analyst George Hill lowered his price target on Medidata (MDSO) to $91, saying his revenue projections are now slightly lower than previously based on the increasing competition in ancillary services. The analyst cites Veeva's (VEEV) recent announcement of a consolidated CDMS solution, IQVIA's (IQV) expansion of its partnership with Salesforce to grow its offerings in clinical technology solutions, and LabCorp's (LH) Covance unit launching a new technology suite earlier this year. Hill contends that while Medidata still has the lead in market share and product development for the clinical trial IT market, keeping an Outperform rating on the stock in the long run, he also warns that the product announcements from competitors could lengthen the company's sales cycle.

MDSO

Medidata

$73.30

-0.83 (-1.12%)

VEEV

Veeva

$105.26

1.36 (1.31%)

IQV

Iqvia

$128.56

0.92 (0.72%)

LH

LabCorp

$169.54

-2.46 (-1.43%)

  • 03

    Oct

  • 24

    Oct

MDSO Medidata
$73.30

-0.83 (-1.12%)

09/11/18
DBAB
09/11/18
NO CHANGE
Target $95
DBAB
Buy
Medidata price target raised to $95 from $90 at Deutsche Bank
Deutsche Bank analyst Glen Santangelo raised his price target for Medidata Solutions to $95 after hosting meetings with CFO Rouven Bergmann. The analyst continues to be excited about the company's opportunities for both revenue growth and margin expansion. With a leading competitive position in an industry with high switching costs, Medidata has the luxury of focusing on the long-term and ensuring high quality products and execution, Santangelo tells investors in a research note. He reiterates a Buy rating on the shares.
07/25/18
NEED
07/25/18
DOWNGRADE
NEED
Hold
Medidata downgraded to Hold from Buy at Needham
07/25/18
NEED
07/25/18
DOWNGRADE
NEED
Hold
Medidata downgraded to Hold at Needham on disappointing Q2 results
As noted earlier, Needham analyst Scott Berg downgraded Medidata to Hold from Buy following its "disappointing" Q2 results and guidance, causing him to lower his organic subscription revenue growth expectations. The analyst points to billings and deferred revenue coming in "substantially below historical trends", suggesting that bookings were "either delayed or lost". Berg adds that the magnitude of those deviations was substantial enough to reset his growth expectations to mid-teens range.
08/06/18
MSCO
08/06/18
NO CHANGE
MSCO
Boeing, Tesla, Nvidia make Morgan Stanley 'key man risk' list
Morgan Stanley equity strategist Mark Savino noted that about 12% of CEO jobs among S&P 500 companies turned over in 2017, noting that this was the highest level of CEO departures since before the financial crisis. The 59 stocks of S&P 500 companies that had CEOs depart in 2017 underperformed the market by 11% over the next 12 months, or since the departure for instances that were less than 12 months ago, noted Savino. In cooperation with the firm's U.S. analysts, Savino and his team identified the companies in each sector they believe face the greatest level of "key man risk," which includes: Boeing (BA), Tesla (TSLA), ADT Inc. (ADT), Moody's (MCO), TransUnion (TRU), Arista Networks (ANET), Church & Dwight (CHD), Coca-Cola (KO), Monster Beverage (MNST), Coupa Software (COUP), Salesforce (CRM), FireEye (FEYE), MongoDB (MDB), Microsoft (MSFT), New Relic (NEWR), XPO Logistics (XPO), Hilton (HLT), Las Vegas Sands (LVS), Best Buy (BBY), Ulta (ULTA), Aflac (AFL), Athene Holding (ATH), Lincoln National (LNC), Arthur J. Gallagher (AJG), Chubb (CB), Amazon.com (AMZN), Activision Blizzard (ATVI), Facebook (FB), Alphabet (GOOGL), Apple (AAPL), Terex (TEX), Cleveland-Cliffs (CLF), Freeport McMoRan (FCX), FleetCor (FLT), Global Payments (GPN), Square (SQ), Jazz Pharmaceuticals (JAZZ), Cheesecake Factory (CAKE), Broadcom (AVGO), Nvidia (NVDA), Chegg (CHGG), DXC Technology (DXC), Medidata (MDSO), Pluralsight (PS), RealPage (RP), Shopify (SHOP) and T-Mobile (TMUS).
VEEV Veeva
$105.26

1.36 (1.31%)

08/24/18
NEED
08/24/18
NO CHANGE
Target $100
NEED
Buy
Veeva price target raised to $100 from $90 at Needham
Needham analyst Scott Berg raised his price target on Veeva to $100 and kept his Buy rating after its "very strong" Q2 results, citing upside in its revenue and higher than expected billings. The analyst cites "sales traction" in several newer products that helped the company extend its subscription revenue growth. Berg also contends that Veeva's "best in class" profitability shifted into a higher gear, adding that its operating margins should be sustainable with the benefits of its data center transition to AWS.
08/24/18
DADA
08/24/18
NO CHANGE
Target $105
DADA
Buy
Veeva price target raised to $105 from $88 at DA Davidson
DA Davidson analyst Rishi Jaluria raised his price target on Veeva to $105 and kept his Buy rating after its "strong beat and raise" quarter. Jaluria states that while the stock was down slightly in the aftermarket, it was up 58% year-to-date ahead of earnings, and also points to a slight miss in deferred revenues in spite of higher than expected billings. The analyst still notes Veeva's impressive momentum with emerging products and successful investment in its core CRM product, adding that the company has received "great feedback" from its rollout of Veeva Sunrise.
08/24/18
MSCO
08/24/18
NO CHANGE
Target $100
MSCO
Overweight
Veeva price target raised to $100 from $91 at Morgan Stanley
Morgan Stanley analyst Stan Zlotsky maintained an Overweight rating on Veeva Systems and raised his price target to $100 from $91 after the company delivered "strong" Q2 results. The analyst continues to view Veeva as a unique software asset deserving premium valuation.
08/24/18
ADAM
08/24/18
NO CHANGE
Target $98
ADAM
Buy
Veeva price target raised to $98 from $85 at Canaccord
Canaccord analyst David Hynes raised his price target on Veeva to $98 from $85 following solid Q2 results. The analyst said the growth continues to be driven by a balance of current customer going deeper with existing deployments, adoption of new Vault products, and gradual expansion outside of the firm's core life sciences market. Although he raised his price target on Autodesk, he is concerned about its premium valuation and would be a better buyer on pullbacks. Hynes reiterated his Buy rating on Veeva shares.
IQV Iqvia
$128.56

0.92 (0.72%)

08/23/18
ARGS
08/23/18
NO CHANGE
Target $136
ARGS
Buy
Iqvia price target raised to $136 from $112 at Argus
Argus analyst Jasper Hellweg raised his price target on Iqvia to $136 and kept his Buy rating, citing its position as the industry leader in contract research organization to benefit from "steady biopharmaceutical funding and a healthy backlog". Hellweg notes that while the company has faced headwinds in implementing its Orchestrated Customer Engagement platform, it also saw margin growth in Q2. The analyst also points to Iqvia's discount valuation, with the stock trading at 22.6-times his expected FY18 earnings, which is below the peer group average of 23.5-times, and believes a higher valuation is warranted given its "new product offerings, technological innovation, and above-peer-average revenue and earnings growth prospects".
08/13/18
WELS
08/13/18
NO CHANGE
Target $140
WELS
Outperform
Iqvia price target raised to $140 from $120 at Wells Fargo
Wells Fargo analyst Jamie Stockton raised his price target for Iqvia to $140 from $120 following a June quarter beat. The analyst reiterates an Outperform rating on the shares.
07/25/18
RHCO
07/25/18
NO CHANGE
Target $140
RHCO
Buy
Iqvia price target raised to $140 from $130 at SunTrust
SunTrust analyst Sandy Draper raised his price target on Iqvia to $140 and kept his Buy rating after its "beat and raise" Q2. The analyst says the quarter produced evidence of top-line synergies, which is incremental to his already bullish outlook calling for "solid organic mid-single digit top-line growth with margin expansion", along with cost synergies post-IMS merger and excess capital deployment. Draper believes that Q2 beat also implies upside potential going forward on strong R&D segment bookings.
08/20/18
STFL
08/20/18
NO CHANGE
Target $150
STFL
Buy
Iqvia growth rate inflection 'just matter of time,' says Stifel
Stifel analyst Shlomo Rosenbaum believes "it is just [a] matter of time before" Iqvia's growth rate inflects given the bookings strength in the Quintiles CRO business, which he notes has a long cycle where bookings precede revenue by a period of time. He believes the company's merger strategy to utilize its comprehensive data to develop a differentiated CRO product is in the early stages of playing out and that investors should buy ahead of that continuing to be evidenced. He maintains a Buy rating and $150 price target on Iqvia shares.
LH LabCorp
$169.54

-2.46 (-1.43%)

06/25/18
LEHM
06/25/18
UPGRADE
Target $130
LEHM
Overweight
Quest Diagnostics upgraded to Overweight from Equal Weight at Barclays
As previously reported, Barclays analyst Jack Meehan upgraded Quest Diagnostics (DGX) to Overweight from Equal Weight and raised his price target to $130 from $120, telling investors in a research note that Quest has a "very favorable" risk-reward profile and current levels. Meehan contends that it "could be a big deal" that UnitedHealth (UNH) will share savings with preferred labs as volume shifts from high-cost settings, a first for the lab industry, and that his primary care physician survey indicates that both Quest and LabCorb (LH) should gain share as payor networks open. Additionally, Meehan says the "pieces are in place" for Quest to more meaningfully leverage its diagnostic data asset with customers. Commenting further on Top Pick LabCorp, Meehan believes industry themes that bode well for Quest also bode well for LabCorp.
09/25/18
PIPR
09/25/18
NO CHANGE
PIPR
Piper sees early winners from annual list of new codes from CMS
The Centers for Medicare & Medicaid Services published its annual list of new codes ahead of the final rate determination including 99 codes, Piper Jaffray analyst William Quirk tells investors in a research note. He says Genomic Health (GHDX), LabCorp (LH), Myriad Genetics (MYGN), Natera (NTRA) and Quest Diagnostics (DGX) look like early winners in the 2019 Preliminary Clinical Laboratory Fee Schedule Fee Schedule determinations, with an incrementally positive competitive move for CareDx (CDNA). The analyst notes that Genomic Health received increased reimbursement for a couple tests and CareDx competitor TAI Diagnostics ends up with a likely longer pathway to reimbursement.
06/27/18
06/27/18
DOWNGRADE

Hold
Deutsche Bank downgrades Quest, LabCorp to Hold with catalysts 'exhausted'
As previously reported, Deutsche Bank analyst Dan Leonard downgraded Quest Diagnostics (DGX) and LabCorp (LH), both to Hold from Buy, stating that he previously believed that hospital labs, which could be more impaired by Medicare reimbursement cuts, would be willing sellers, but the slower than expected pace of deals has made him question this assumption. He continues to see durable organic growth for Quest's and LabCorp's diagnostics businesses, but he now wonders if some headwinds had abated in the way he'd previously assumed, Leonard added.
06/27/18
DBAB
06/27/18
DOWNGRADE
DBAB
Hold
LabCorp downgraded to Hold from Buy at Deutsche Bank

TODAY'S FREE FLY STORIES

SQM

SQM

$30.86

-1.82 (-5.57%)

18:51
05/23/19
05/23
18:51
05/23/19
18:51
Downgrade
SQM rating change  »

SQM downgraded to Market…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

VSAT

ViaSat

$87.89

-1.63 (-1.82%)

, DECK

Deckers Brands

$147.27

-2.94 (-1.96%)

18:50
05/23/19
05/23
18:50
05/23/19
18:50
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: Viasat…

VSAT

ViaSat

$87.89

-1.63 (-1.82%)

DECK

Deckers Brands

$147.27

-2.94 (-1.96%)

DXC

DXC Technology

$52.00

-2.5 (-4.59%)

HPQ

HP Inc.

$19.20

-0.095 (-0.49%)

INTU

Intuit

$241.30

-6.22 (-2.51%)

NVCR

Novocure

$49.40

-1.92 (-3.74%)

CTL

CenturyLink

$9.66

-0.29 (-2.91%)

ADSK

Autodesk

$169.64

-4.47 (-2.57%)

LGF.A

Lionsgate

$15.96

-0.06 (-0.37%)

ROST

Ross Stores

$94.54

-0.06 (-0.06%)

SPLK

Splunk

$128.68

-7.12 (-5.24%)

HPE

HP Enterprise

$14.33

-0.21 (-1.44%)

DVAX

Dynavax

$6.36

(0.00%)

RTIX

RTI Surgical

$4.40

-0.08 (-1.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 23

    May

  • 23

    May

  • 23

    May

  • 23

    May

  • 23

    May

  • 23

    May

  • 23

    May

  • 23

    May

  • 23

    May

  • 28

    May

  • 29

    May

  • 30

    May

  • 31

    May

  • 05

    Jun

  • 05

    Jun

  • 06

    Jun

  • 07

    Jun

  • 08

    Jun

  • 09

    Jun

  • 10

    Jun

  • 10

    Jun

  • 12

    Jun

  • 13

    Jun

  • 17

    Jun

  • 09

    Jul

EPE

EP Energy

$0.16

(0.00%)

18:32
05/23/19
05/23
18:32
05/23/19
18:32
Hot Stocks
EP Energy suspends NYSE trading, begins trading on OTC markets »

EP Energy confirmed that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMUS

T-Mobile

$76.07

-0.28 (-0.37%)

, NFLX

Netflix

$352.23

-7.47 (-2.08%)

18:15
05/23/19
05/23
18:15
05/23/19
18:15
Hot Stocks
T-Mobile says new Magenta plan will include Netflix Basic for families »

T-Mobile (TMUS) said…

TMUS

T-Mobile

$76.07

-0.28 (-0.37%)

NFLX

Netflix

$352.23

-7.47 (-2.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 03

    Jun

  • 03

    Jun

  • 06

    Jun

  • 13

    Jun

  • 25

    Jun

HOPE

Hope Bancorp

$13.23

-0.5 (-3.64%)

18:06
05/23/19
05/23
18:06
05/23/19
18:06
Hot Stocks
Hope Bancorp names Kevin S. Kim chairman of the board »

Hope Bancorp, Inc.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

CTL

CenturyLink

$9.66

-0.29 (-2.91%)

18:06
05/23/19
05/23
18:06
05/23/19
18:06
Hot Stocks
CenturyLink CEO buys 50K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXR

Extra Space Storage

$106.85

0.59 (0.56%)

18:00
05/23/19
05/23
18:00
05/23/19
18:00
Hot Stocks
Extra Space Storage raises quarterly dividend by 4.7% to 90c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

  • 04

    Jun

HPQ

HP Inc.

$19.20

-0.095 (-0.49%)

17:58
05/23/19
05/23
17:58
05/23/19
17:58
Hot Stocks
HP Inc. says continue to expect FY19 free cash flow of at least $3.7B »

Guidance from the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 29

    May

HPQ

HP Inc.

$19.20

-0.095 (-0.49%)

17:57
05/23/19
05/23
17:57
05/23/19
17:57
Hot Stocks
HP Inc CFO sees FY19 tax rate of about 19% »

Says FY19 EPS outlook of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 29

    May

BA

Boeing

$350.57

-1.93 (-0.55%)

17:56
05/23/19
05/23
17:56
05/23/19
17:56
Periodicals
FAA tells U.N. it sees 737 MAX approval as soon as late June, Reuters says »

FAA representatives…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 05

    Jun

BA

Boeing

$350.57

-1.93 (-0.55%)

, UAL

United Continental

$80.91

-0.94 (-1.15%)

17:52
05/23/19
05/23
17:52
05/23/19
17:52
Periodicals
Airlines see 737 MAX needing 100-150 hours of preparation, Reuters says »

Officials from three U.S.…

BA

Boeing

$350.57

-1.93 (-0.55%)

UAL

United Continental

$80.91

-0.94 (-1.15%)

AAL

American Airlines

$29.49

-0.43 (-1.44%)

LUV

Southwest

$50.97

-1.6 (-3.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 05

    Jun

  • 12

    Jun

  • 12

    Jun

  • 25

    Jul

  • 13

    Nov

HPQ

HP Inc.

$19.20

-0.095 (-0.49%)

17:50
05/23/19
05/23
17:50
05/23/19
17:50
Hot Stocks
HP Inc CFO says continued to 'outperform PC market and gain profitable share' »

Says commercial portfolio…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 29

    May

TCCO

Technical Comm Corp

$3.48

(0.00%)

17:48
05/23/19
05/23
17:48
05/23/19
17:48
Hot Stocks
Technical Comm Corp receives compliance and plan acceptance notices from Nasdaq »

Technical Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPQ

HP Inc.

$19.20

-0.095 (-0.49%)

17:42
05/23/19
05/23
17:42
05/23/19
17:42
Hot Stocks
HP Inc. says PC growth across industry was subdued this quarter »

Continue to gain momentum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 29

    May

RST

Rosetta Stone

$24.93

1.135 (4.77%)

17:38
05/23/19
05/23
17:38
05/23/19
17:38
Hot Stocks
Rosetta Stone officer Sonia Galindo sells over $107K in company shares »

Rosetta Stone officer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 27

    Jun

CCF

Chase Corporation

$100.72

0.32 (0.32%)

17:32
05/23/19
05/23
17:32
05/23/19
17:32
Hot Stocks
Chase Corporation chairman sells 2K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RNR

RenaissanceRe

$170.85

-0.34 (-0.20%)

17:24
05/23/19
05/23
17:24
05/23/19
17:24
Syndicate
Breaking Syndicate news story on RenaissanceRe »

RenaissanceRe files $750M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTIX

RTI Surgical

$4.40

-0.08 (-1.79%)

17:21
05/23/19
05/23
17:21
05/23/19
17:21
Syndicate
Breaking Syndicate news story on RTI Surgical »

RTI Surgical files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 17

    Jun

DXC

DXC Technology

$52.00

-2.5 (-4.59%)

17:21
05/23/19
05/23
17:21
05/23/19
17:21
Earnings
DXC Technology sees FY20 adjusted EPS $7.75-$8.50, consensus $9.21 »

Sees FY20 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

RTIX

RTI Surgical

$4.40

-0.08 (-1.79%)

17:19
05/23/19
05/23
17:19
05/23/19
17:19
Syndicate
Breaking Syndicate news story on RTI Surgical »

RTI Surgical files $100M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 17

    Jun

RTN

Raytheon

$179.79

-1.01 (-0.56%)

17:15
05/23/19
05/23
17:15
05/23/19
17:15
Hot Stocks
Raytheon awarded $355.49M Navy contract for AGM-88B missiles »

Raytheon has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 05

    Jun

DVAX

Dynavax

$6.36

(0.00%)

17:15
05/23/19
05/23
17:15
05/23/19
17:15
Hot Stocks
Breaking Hot Stocks news story on Dynavax 

Dynavax trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 31

    May

  • 05

    Jun

COST

Costco

$248.62

-0.93 (-0.37%)

17:11
05/23/19
05/23
17:11
05/23/19
17:11
Recommendations
Costco analyst commentary  »

Baird recommends…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

MYND

MYnd Analytics

$1.16

0.14 (13.73%)

17:06
05/23/19
05/23
17:06
05/23/19
17:06
Hot Stocks
MYnd Analytics director John Pappajohn purchases 200K shares of company stock »

MYnd Analytics director…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBOE

Cboe Global Markets

$106.40

-1.45 (-1.34%)

17:05
05/23/19
05/23
17:05
05/23/19
17:05
Hot Stocks
Cboe Global Markets EVP Harkins sells 4.3K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.